Elixinol Global Ltd
Elixinol Wellness Limited, a holding company, provides healthy products in Australia, the Americas, and internationally. The company provides human nutrition, human wellness, pet wellness, and superfood ingredients under Hemp Foods Australia, Mt Elephant, The Healthy Chef, Soul Foods, Ananda Equine, and Field Day brands. It distributed through grocery, wholesale, and e-commerce channels for white… Read more
Market Cap & Net Worth: Elixinol Global Ltd (ELLXF)
Elixinol Global Ltd (PINK:ELLXF) has a market capitalization of $6.50 Million ($6.50 Million) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #35559 globally and #11587 in its home market, demonstrating a -18.65% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Elixinol Global Ltd's stock price $0.02 by its total outstanding shares 413987731 (413.99 Million).
Elixinol Global Ltd Market Cap History: 2018 to 2025
Elixinol Global Ltd's market capitalization history from 2018 to 2025. Data shows change from $749.32 Million to $6.50 Million (-47.46% CAGR).
Elixinol Global Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Elixinol Global Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.71x
Elixinol Global Ltd's market cap is 0.71 times its annual revenue
1.02x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2018 | $749.32 Million | $37.13 Million | -$860.00K | 20.18x | N/A |
| 2019 | $166.01 Million | $30.71 Million | -$80.62 Million | 5.40x | N/A |
| 2020 | $58.79 Million | $15.01 Million | -$104.51 Million | 3.92x | N/A |
| 2021 | $22.07 Million | $9.34 Million | -$17.02 Million | 2.36x | N/A |
| 2022 | $5.26 Million | $7.05 Million | -$10.57 Million | 0.75x | N/A |
| 2023 | $3.56 Million | $8.27 Million | -$7.51 Million | 0.43x | N/A |
| 2024 | $10.60 Million | $14.96 Million | -$1.72 Million | 0.71x | N/A |
Competitor Companies of ELLXF by Market Capitalization
Companies near Elixinol Global Ltd in the global market cap rankings as of March 18, 2026.
Key companies related to Elixinol Global Ltd by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #410 globally with a market cap of $53.52 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #457 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #721 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #410 | Zoetis Inc | NYSE:ZTS | $53.52 Billion | $121.68 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.60 |
| #457 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #721 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
Elixinol Global Ltd Historical Marketcap From 2018 to 2025
Between 2018 and today, Elixinol Global Ltd's market cap moved from $749.32 Million to $ 6.50 Million, with a yearly change of -47.46%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $6.50 Million | -38.67% |
| 2024 | $10.60 Million | +197.67% |
| 2023 | $3.56 Million | -32.28% |
| 2022 | $5.26 Million | -76.17% |
| 2021 | $22.07 Million | -62.46% |
| 2020 | $58.79 Million | -64.59% |
| 2019 | $166.01 Million | -77.85% |
| 2018 | $749.32 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Elixinol Global Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $6.50 Million USD |
| MoneyControl | $6.50 Million USD |
| MarketWatch | $6.50 Million USD |
| marketcap.company | $6.50 Million USD |
| Reuters | $6.50 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.